Extracts of newspaper publications dated May 30, 2026 of the audited Standalone and Consolidated financial results for the quarter and year ended March 31, 2026.
CONCORDBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Concord Biotech Ltd has announced the publication of its audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. The results were published on May 30, 2026 in Financial Express (English, all editions) and Financial Express (Gujarati, Ahmedabad edition). The company filed this intimation under Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which mandates newspaper publication of quarterly and annual financial results. The full detailed financial results are also available on the company's website at www.concordbiotech.com.
The filing confirms regulatory compliance with listing obligations. The actual financial numbers and performance details are contained in the newspaper extracts and full filings, not in this intimation letter itself. Shareholders should refer to the detailed results published separately for assessing company performance.